Skip to main content
Article thumbnail
Location of Repository

An unexpected phosphate binding site in Glyceraldehyde 3-Phosphate Dehydrogenase: Crystal structures of apo, holo and ternary complex of Cryptosporidium parvum enzyme

By William J Cook, Olga Senkovich and Debasish Chattopadhyay
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2003). A: Crystal structure of two ternary complexes of phosphorylating glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus with NAD and D-glyceraldehyde 3-phosphate.
    2. (1991). Accurate bond and angle parameters for Xray protein structure refinement. Acta Crystallogr
    3. (1999). Biochemical peculiarities and drug targets in Cryptosporidium parvum: lessons from other Coccidian parasites. Parasitol Today
    4. (1998). Branlant G: Comparative study of the catalytic domain of phosphorylating glyceraldehyde-3-phosphate dehydrogenases from bacteria and archaea via essential cysteine probes and site-directed mutagenesis.
    5. (2005). Chattopadhyay D: Crystallization of three key glycolytic enzymes of the opportunistic pathogen Cryptosporidium parvum. Biochim Biophys Acta
    6. (2004). Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science
    7. (1996). Coombs G: Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii. Mol Biochem Parasitol
    8. (2008). Corbier C: Trapping of the thioacyl-glyceraldehyde-3-phosphate dehydrogenase intermediate from Bacillus stearothermophilus: direct evidence for a flip-flop mechanism.
    9. (2004). Cowtan K: Coot: model-building tools for molecular graphics. Acta Crystallogr
    10. (2002). Cryptosporidiosis: biology, pathogenesis and disease. Microb Infect
    11. (2003). Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-D-glyceric acid.
    12. (1997). EJ: Refinement of macromolecular structures by the maximum-likelihood method. Acta Cryst
    13. (2003). Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure. Biochemistry
    14. (1998). GL: Crystallography and NMR system (CNS): A new software system for macromolecular structure determination. Acta Crystallgr
    15. (1976). Glyceraldehyde-3-phosphate dehydrogenase, in The Enzymes. Volume 13. 3rd edition. Edited by: Boyer PD.
    16. (1998). Griffiths JK: Natural history and biology of Cryptosporidium parvum. Adv Parasitol
    17. (2003). Grütter MG: Structure of rabbit-muscle glyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr
    18. (2000). H-W: Structural analysis of glyceraldehyde 3-phosphate dehydrogenase from Escherichia coli: direct evidence of substrate binding and cofactorinduced conformational changes. Biochemistry
    19. (2006). High resolution structure of human Dglyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr
    20. (2001). Hol WG: Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
    21. (1995). Hol WGJ: Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: Implications for structurebased drug design and a new position for the inorganic phosphate binding site. Biochemistry
    22. (1997). Mascaro C: Glycolytic enzyme activities in Cryptosporidium parvum oocysts.
    23. (1975). MG: Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase.
    24. (2001). MH: Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    25. (1998). MH: Synthesis and structure-activity relationships of adenosine analogs as inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase. Modifications at positions 5' and 8. Bioorg Med Chem Lett
    26. (2002). Okhuyesen PC: HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep
    27. (2000). Opperdoes FR: Comparative study of Leishmania mexicana and Trypanosoma brucei NAD-dependent glycerol-3-phosphate dehydrogenase. Mol Biochem Parasitol
    28. (2005). PM: Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum. Acta Crystallogr
    29. (2002). RL: Cryptosporidiosis: epidemiology and impact. Microb Infect
    30. (1996). Rogalska E, Branlant G: Phosphate-binding sites in phosphorylating glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus.
    31. (1968). Solvent content of protein crystals.
    32. (2007). Soukri A: Purification and characterization of cytosolic glyceraldehyde-3-phosphate dehydrogenase from the dromedary camel. Acta Biochim Biophys Sin
    33. (2002). Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 Å resolution. FEBS Lett
    34. (1991). The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes.
    35. (1995). The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae. Ann Trop Med Parasitol
    36. (1977). TP: Isolation and characterization of multiple molecular forms of cytosolic NAD-linked glycerol-3-phosphate dehydrogenase from normal and neoplastic rabbit tissues.
    37. (1987). Wonacott AJ: Structure of holo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus at 1.8 Å resolution.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.